Provided by Tiger Trade Technology Pte. Ltd.

AngioDynamics

11.23
-2.9600-20.86%
Post-market: 11.280.0487+0.43%18:40 EDT
Volume:3.06M
Turnover:35.45M
Market Cap:472.27M
PE:-12.69
High:13.80
Open:13.22
Low:11.06
Close:14.19
52wk High:16.29
52wk Low:9.39
Shares:42.05M
Float Shares:32.51M
Volume Ratio:3.55
T/O Rate:9.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8848
EPS(LYR):-0.8848
ROE:-20.77%
ROA:-5.13%
PB:2.76
PE(LYR):-12.69

Loading ...

AngioDynamics wins FDA IDE approval for RELIEF feasibility study of NanoKnife in BPH

Reuters
·
Jun 17

AngioDynamics Receives FDA Ide Approval for Relief Feasibility Study Evaluating Nanoknife Ire Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (Bph)

THOMSON REUTERS
·
Jun 17

AngioDynamics Targets BPH Market With New NanoKnife Trial: What Investors Should Watch

TIPRANKS
·
Jun 12

AngioDynamics lifts FY2026 net sales outlook to $313.5-$315.5 million

Reuters
·
Jun 10

BRIEF-AngioDynamics Says Palmetto GBA finalizes Medicare Nanoknife coverage from July 5, 2026

Reuters
·
May 29

AngioDynamics Medicare coverage for NanoKnife IRE in prostate, liver cancer takes effect July 2026

Reuters
·
May 29

AngioDynamics - Palmetto Gba Issues Final Lcd for Medicare Coverage of Nanoknife Ire Effective July 5, 2026

THOMSON REUTERS
·
May 29

AngioDynamics to present at Goldman Sachs Global Healthcare Conference

Reuters
·
May 27

AngioDynamics Reports 'Durable Oncologic Control' in Study of NanoKnife for Intermediate-Risk Prostate Cancer

MT Newswires Live
·
May 13

AngioDynamics reports durable 2-year NanoKnife outcomes in PRESERVE prostate cancer trial

Reuters
·
May 13

AngioDynamics Announces Two-Year Preserve Trial Data Demonstrating Durable Nanoknife Ire System Outcomes in Intermediate-Risk Prostate Cancer

THOMSON REUTERS
·
May 13

AngioDynamics Files Patent Suit to Protect Thrombectomy Technology

TIPRANKS
·
Apr 24

BRIEF-Angiodynamics Files Patent Infringement Lawsuit Against Endovascular Engineering On April 23, 2026

Reuters
·
Apr 24

AngioDynamics - Files Patent Infringement Lawsuit Against Endovascular Engineering on April 23, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 24

AngioDynamics sues Endovascular Engineering over alleged Hēlo Thrombectomy System patent infringement

Reuters
·
Apr 24